| Gregory Freitag , CEO, HTS BioSystems. HTS has identified and assembled proprietary detection technologies and strategic partnerships to create its PROTEOMATRIX TM Portfolio. From the Proteomatrix Portfolio HTS is integrating technologies and products to provide solutions to the Proteomics research market. mnvcc
Websites about Gregory Freitag
Directory
| |
